(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 24.08%67.54B | 29.14%50.84B | 29.68%35.86B | 23.76%20.77B | -19.57%54.43B | -20.47%39.36B | -22.17%27.65B | -7.45%16.78B | 28.67%67.68B | 40.87%49.5B |
Operating income | 24.08%67.54B | 29.14%50.84B | 29.68%35.86B | 23.76%20.77B | -19.57%54.43B | -20.47%39.36B | -22.17%27.65B | -7.45%16.78B | 28.67%67.68B | 40.87%49.5B |
Cost of sales | -17.98%-46.69B | ---- | -36.19%-25.1B | ---- | 12.80%-39.57B | ---- | 16.46%-18.43B | ---- | -41.25%-45.38B | ---- |
Operating expenses | -17.98%-46.69B | -28.15%-34.7B | -36.19%-25.1B | -33.14%-14.75B | 12.80%-39.57B | 14.08%-27.08B | 16.46%-18.43B | -0.87%-11.08B | -41.25%-45.38B | -50.17%-31.51B |
Gross profit | 40.33%20.85B | 31.33%16.14B | 16.67%10.75B | 5.56%6.02B | -33.34%14.86B | -31.68%12.29B | -31.52%9.22B | -20.22%5.71B | 8.92%22.29B | 27.08%17.99B |
Selling expenses | -117.13%-10.74B | -162.28%-6.94B | -105.08%-5.05B | -40.14%-2.05B | 8.52%-4.95B | -28.36%-2.65B | 41.30%-2.46B | 34.55%-1.46B | 44.48%-5.41B | 77.97%-2.06B |
Administrative expenses | -1.10%-2.6B | -15.74%-1.54B | -13.51%-1.22B | -3.58%-446.46M | 5.16%-2.57B | -4.08%-1.33B | 1.47%-1.07B | 18.88%-431.04M | -33.74%-2.71B | -13.53%-1.28B |
Research and development expenses | -49.69%-58.42M | ---9.78M | ---825K | ---699.06K | ---39.03M | ---- | ---- | ---- | ---- | ---- |
Profit from asset sales | ---- | -53.02%1.09M | ---- | -123.95%-196.59K | ---- | 286.02%2.31M | ---- | --820.78K | ---- | --599.1K |
Impairment and provision | -64.00%2.58M | -44.35%-473.95M | -50.38%3.76M | -407.71%-139.97M | 130.70%7.16M | -110.31%-328.34M | 342.46%7.58M | 1,811.40%45.49M | -228.67%-23.32M | -866.44%-156.12M |
-Other impairment is provision | -64.00%2.58M | -44.35%-473.95M | -50.38%3.76M | -407.71%-139.97M | 130.70%7.16M | -110.31%-328.34M | 342.46%7.58M | 1,811.40%45.49M | -228.67%-23.32M | -866.44%-156.12M |
Special items of operating profit | 255.24%1.49B | -72.08%68.58M | 290.58%636.84M | -65.32%17.59M | -46.58%420.08M | -25.37%245.63M | -174.86%-334.17M | -64.76%50.73M | -19.71%786.3M | -39.08%329.14M |
Operating profit | 15.75%8.95B | -17.91%5.99B | -4.24%5.13B | -16.92%2.84B | -48.25%7.73B | -45.90%7.3B | -37.86%5.36B | -24.44%3.42B | 54.03%14.94B | 218.50%13.49B |
Financing cost | -53.41%-297.89M | 193.04%581.83M | -45.13%-161.2M | 289.80%310.32M | 12.48%-194.18M | -991.32%-625.37M | -4.28%-111.07M | 251.89%79.61M | -2.39%-221.86M | 64.19%-57.3M |
Share of profits of associates | -33.58%109.56M | ---- | -73.36%24.03M | ---- | -0.04%164.94M | ---- | 156.19%90.2M | ---- | 880.60%165.02M | ---- |
Share of profit from joint venture company | -396.41%-12.17M | ---- | 140.24%1.6M | ---- | 8.72%-2.45M | ---- | -123.18%-3.99M | ---- | -95.27%-2.69M | ---- |
Special items of earning before tax | ---- | 123.46%1.99M | ---- | 52.47%2.17M | ---- | 0.84%-8.49M | ---- | --1.42M | ---- | ---8.56M |
Earning before tax | 13.62%8.75B | -1.34%6.57B | -6.33%5B | -9.93%3.16B | -48.25%7.7B | -50.36%6.66B | -37.62%5.33B | -21.88%3.5B | 56.67%14.88B | 228.84%13.42B |
Tax | 1.92%-1.4B | -0.77%-1.15B | -9.89%-859.9M | -17.52%-690.06M | 41.44%-1.43B | 49.48%-1.14B | 61.16%-782.48M | 44.46%-587.18M | -2.12%-2.44B | -126.67%-2.26B |
After-tax profit from continuing operations | 17.16%7.35B | -1.78%5.42B | -9.12%4.14B | -15.45%2.47B | -49.59%6.27B | -50.53%5.52B | -30.37%4.55B | -14.91%2.92B | 75.00%12.44B | 261.84%11.16B |
Earning after tax | 17.16%7.35B | -1.78%5.42B | -9.12%4.14B | -15.45%2.47B | -49.59%6.27B | -50.53%5.52B | -30.37%4.55B | -14.91%2.92B | 75.00%12.44B | 261.84%11.16B |
Minority profit | -51.82%557.91M | -75.71%216.93M | -60.46%229.13M | -53.22%165.2M | -57.35%1.16B | -66.58%893.09M | -49.23%579.46M | -36.74%353.15M | 130.45%2.71B | 54,742.95%2.67B |
Profit attributable to shareholders | 32.77%6.79B | 12.49%5.21B | -1.63%3.91B | -10.25%2.3B | -47.42%5.11B | -45.48%4.63B | -26.38%3.97B | -10.66%2.56B | 63.99%9.73B | 175.65%8.49B |
Basic earnings per share | 27.72%3.282 | 6.79%2.5165 | -7.17%1.8887 | -15.29%1.1121 | -48.42%2.5697 | -45.80%2.3566 | -26.37%2.0345 | -10.66%1.3129 | 63.98%4.9817 | 175.65%4.3479 |
Diluted earnings per share | 27.72%3.282 | 6.79%2.5165 | -7.17%1.8887 | -15.29%1.1121 | -48.42%2.5697 | -45.80%2.3566 | -26.37%2.0345 | -10.66%1.3129 | 63.98%4.9817 | 175.65%4.3479 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young (Special General Partnership), Ernst & Young | -- | -- | -- | KPMG | -- | -- | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data